Drug
18f Metafluorobenzylguanidine
18f Metafluorobenzylguanidine: highest development phase Phase 2, developed by Illumina. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Illumina
Trials
| Drug | Phase | Indication |
|---|---|---|
| 18F-metaFluorobenzylguanidine NCT06965621 | Phase 2 | Heart Failure |
Latest
No recent events.
Follow 18f Metafluorobenzylguanidine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.